Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Glioblastoma 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Glioma 3Brain Neoplasms 3Uterine Cervical Dysplasia 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Neuroblastoma 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Atypical Squamous Cells of the Cervix 2Astrocytoma 2Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Testicular Neoplasms 1Teratoma 1Squamous Intraepithelial Lesions 1Spinal Cord Neoplasms 1Smoking Cessation 1Smoking 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1

Interventions

Endoscopy 2Eicosapentaenoic Acid 2pegvisomant 1alovudine 1Tirzepatide 1Restraint, Physical 1Microspheres 1Metformin 1Colonoscopy 1Clinical Chemistry Tests 1Cholecalciferol 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hyperplasia × Restraint, Physical × Clear all
NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡